WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical …
Link to Full Article: Read Here
Jul 27, 2020 | News Stories
WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical …
Link to Full Article: Read Here